united therapeutics corporation american publicly traded biotechnology public benefit listed nasdaq symbol develops novel lifeextending technologies patients areas lung disease organ manufacturing united therapeutics coheadquartered silver spring maryland research triangle park north carolina additional facilities magog bromont quebec melbourne jacksonville florida blacksburg virginia manchester new united therapeutics founded martine american lawyer author entrepreneur created sirius xm rothblatts young daughter diagnosed fatal orphan disease pulmonary arterial hypertension rothblatt sold telecom stock started pph cure foundation fund pah us food drug administration fda approved united therapeutics drug prostacyclin vasodilator used treat pah remodulin provided pah patients alternative glaxosmithklines remodulin annual sales reached annual sales million united therapeutics share price increased percent initial public offering united therapeutics acquired revivicor company focused developing genetic biotechnology platforms provide alternative tissue sources company acquired steadymed medical device company developing injectable therapeutic drugs pulmonary acquisitions include synquest cooke pharma united therapeutics entered numerous licensing agreements collaborations companies eli lilly company deka research development mannkind national cancer institute january united therapeutics market capitalization january porcine heart provided united therapeutics revivicor subsidiary conjunction university maryland medical center used first pigtohuman transplant recipient subsequently died march united therapeutics products sold us canada products available central south america europe middle east asia various distribution us company received multiple approvals food drug cover various strengths routes administration orenitram remodulin tyvaso tyvaso dpi indicated treatment pulmonary arterial hypertension tyvaso tyvaso dpi also indicated treatment pulmonary hypertension associated interstitial lung disease phild united therapeutics also markets adcirca tadalafil treatment pulmonary arterial hypertension licensing agreement eli lilly february us food drug administration granted clearance unity subcutaneous delivery system remodulin injection also known remunity pump allowing system used drug cassettes prefilled specialty remunity system allows constant subcutaneous undertheskin delivery remodulin remunity system indicated treatment pulmonary arterial hypertension patients older march us fda approved united therapeutics biologics license application bla unituxin monoclonal antibody used secondline treatment children highrisk neuroblastoma rare form cancer may us fda approved united therapeutics new drug application nda tyvaso tyvaso dpi dry powder inhaler containing treprostinil indicated pah phild united therapeutics advancing pipeline research development projects includes new indications formulations delivery devices existing products companys rd pipeline includes five registration phase studies primarily rare lung diseases seven preclinical product leads primarily organ manufacturing february united therapeutics reported successfully completed increase study tyvaso patients pulmonary hypertension associated interstitial lung disease phild study met primary endpoint demonstrating improvement sixminute walk distance company submitted increase study results us food drug administration support efficacy supplement tyvaso new drug application received approval march ongoing clinical trials new medicines include advance outcomes phase ralinepag pulmonary arterial hypertension registration study centralized lung evaluation teton teton idiopathic pulmonary fibrosis united therapeutics developing unique type biopharmaceutical medicinal product known manufactured organ type biologic would transplanted patient substitute failing organ company regenerative medicine products developed via xenotransplantation allogenic recellularization autologous bioprinting researchers new york university used thymokidney xenokidney first transplant genetically engineered nonhuman kidney braindead human body observing kidney function researchers university alabama birmingham used ukidney xenokidney transplant braindead recipient observing kidney function engineers company unither bioelectronics subsidiary conducted first flight human lungs transplant toronto western hospital toronto general lungs successfully transplanted alain hodak engineer ottawa uheart xenoheart used first pig heart living human transplant transplanted pig heart ten genetic modifications pig martine rothblatt debuted printed lung scaffold called one complex printed objects ever printed lung scaffold contained trillion voxels laid kilometers pulmonary capillaries million pulmonary alveoli united therapeutics owns combination laboratory office building complex silver spring maryland facility serves companys coheadquarters used commercial manufacturing active pharmaceutical ingredients finished dosage form products united therapeutics also owns combination manufacturing plant office building research triangle park north carolina facility serves companys coheadquarters occupied clinical research development commercialization logistics manufacturing packaging personnel adjacent research triangle park complex united therapeutics owns site containing approximately square feet building space used research development manufacturing related companys lung regeneration program site available future united therapeutics subsidiaries include lung biotechnology pbc lung bioengineering inc united therapeutics europe ltd unither biotech inc canada unither pharma llc unither telmed ltd unither bio√©lectronique quebec revivicor december united therapeutics global workforce wholly owned subsidiary lung biotechnology pbc united therapeutics addressing acute national shortage transplantable lungs company focuses lung perfusion develop new advanced technologies preserve lungs transplant increase availability lung transplants endstage lung disease including pah lung biotechnology work includes innovative methods stabilize improve lungs would otherwise discarded acquisition revivicor inc united therapeutics began xenokidney program find alternative sources organs patients awaiting kidney transplant xenotransplantation potential solution potentially could provide limitless supply organs lung biotechnology first public benefit corporation subsidiary public biotechnology pharmaceutical united therapeutics established minimum living wage approximately per year employees inclusive incentive pay fulltime employees shareholders company united therapeutics longterm incentive programs united therapeutics recognized one top corporate citizens field us drug manufacturing along companies amgen johnson johnson bristolmyers united therapeutics named fortune best workplaces health care biopharma third consecutive year washington post top workplaces sixth consecutive year fortune best small medium workplaces third consecutive year fortune best workplaces united therapeutics received women technology corporate board award named triangle business journal best places work list sixth consecutive company also named newsweek america responsible companies list united therapeutics facilities include one platinum two gold leed certified buildings rated us green building council four net zero buildings located across three states innovative energyefficient building design multiple solar arrays purchase renewable energy credits recs carbon offsets green energy technologies enabled united therapeutics achieve sustainable urban campus time construction united therapeutics site netzero unisphere square foot highrise office building silver spring maryland largest urban office building energy positive using extensive solar arrays heat mediating wells leadingedge design technologies unisphere generates energy site consumes united therapeutics implemented corporate governance best practices ahead industry peers russell include adopting majority voting proxy access policies initiating board declassification process imposing tighter limit director outside board membership board directors engages company shareholders multiple times year discuss governance operations priorities united therapeutics published comprehensive corporate social responsibility united therapeutics shareholders approved conversion company public benefit corporation pbc united therapeutics creating value shareholders must also consider best interests materially affected companys conduct specific public benefit chooses adopt charter pbcs like united therapeutics intended produce public benefits operate responsible sustainable manner united therapeutics public benefit purpose provide brighter future patients development novel pharmaceutical therapies b technologies expand availability transplantable organs martine aliana rothblatt founder board united therapeutics graduated university california los angeles jd mba degrees june earned phd medical ethics barts london school medicine dentistry queen mary university london rothblatt worked washington dc first field communications satellite law eventually life sciences projects like human genome project also served ceo geostar creator siriusxm satellite michael benkowitz serves president chief operating officer james edgemond chief financial officer treasurer paul mahon general counsel httpsenwikipediaorgwikiunitedtherapeutics